FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,000 | -57.7% | 15,971 | -1.2% | 0.00% | – |
| Q2 2023 | $78,000 | -17.0% | 16,171 | -2.9% | 0.00% | – |
| Q1 2023 | $94,000 | -40.9% | 16,656 | +5.6% | 0.00% | – |
| Q4 2022 | $159,000 | -59.3% | 15,775 | -9.7% | 0.00% | -100.0% |
| Q3 2022 | $391,000 | +49.8% | 17,469 | +67.2% | 0.00% | 0.0% |
| Q2 2022 | $261,000 | -63.4% | 10,450 | -43.1% | 0.00% | -50.0% |
| Q1 2022 | $714,000 | -29.9% | 18,361 | +5.9% | 0.00% | 0.0% |
| Q4 2021 | $1,019,000 | +30.8% | 17,345 | +31.8% | 0.00% | 0.0% |
| Q3 2021 | $779,000 | -34.4% | 13,163 | -5.6% | 0.00% | -33.3% |
| Q2 2021 | $1,188,000 | +118.8% | 13,950 | +112.9% | 0.00% | +50.0% |
| Q1 2021 | $543,000 | – | 6,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |